Jim Hagedorn

Scotts Miracle-Gro Reaffirms $1B Cash Flow Target, Reduces EBITDA Earnings Expectations, Cost-Saving On Track
Scotts Miracle-Gro's Cannabis-Focused Subsidiary Reports 39% YoY Revenue Drop In Q1
Scotts Miracle-Gro Co. Reveals Fiscal 2023 & 4Q Results, Hawthorne Subsidiary Performance
Scotts Miracle-Gro's Cannabis-Focused Subsidiary Reports 39% YoY Revenue Drop In Q1
Scotts Miracle-Gro Co. Reveals Fiscal 2023 & 4Q Results, Hawthorne Subsidiary Performance
The Scotts Miracle-Gro Q3 FY23 Net Sales Decline 6% YoY, Here Are The Details
ScottsMiracle-Gro Provides Update On Fiscal Q2 2023, Announces Nate Baxter Joining Executive Team

Jim Hagedorn Recent News

ScottsMiracle-Gro Appoints Ex Nevada Governor Brian Sandoval To Its Board Of Directors
The Scotts Miracle-Gro Company (NYSE: SMG) appointed Brian Sandoval to its board of directors.
Scotts Miracle-Gro Hits Record Q2 U.S. Consumer Sales & Acquires Australia-Based Cyco, Here Is What You Need To Know
Scotts Miracle-Gro (NYSE: SMG), announced record second-quarter sales in its U.S. consumer segment driven by continued support from its major retail partners.
Scotts Miracle-Gro Studies Growth Opportunities And Potential Spin-Off For Hawthorne
Scotts Miracle-Gro Co.
ScottsMiracle-Gro Announces Record Full Year Results, Outlines 2022 Guidance, Announces Share Repurchases Of $300M
On Wednesday Scotts Miracle-Gro (NYSE: SMG) released record full-year financial results driven by a company-wide sales increase of 19% to $4.93 billion, compared with $4.13 billion a year earlier and continued growth in all major operating segments.
ScottsMiracle-Gro Creates New Entity With $150M Strategic Investment To Enable Cannabis Industry Financing
ScottsMiracle-Gro Company's (NYSE: SMG) newly created cannabis-focused subsidiary, The Hawthorne Collective, is lending $150 million to RIV Capital (TSX: RIV) (OTC: CNPOF).
Scotts Miracle-Gro Sees Record Q3: 48% YoY Increase To $422M, Will Acquire HydroLogic Purification Systems
Scotts Miracle-Gro (NYSE: SMG) reported on Wednesday that company-wide third-quarter sales grew by 8% year-over-year to $1.61 billion, driven mainly by Hawthorne growth of 48%.
Scotts Miracle-Gro Posts Q2 Results, Hawthorne Cannabis Subsidiary Sales Increase 66% YoY To $364M
Scotts Miracle-Gro (NYSE: SMG) reported Wednesday that company-wide sales grew by 32% year-over-year reaching $1.83 billion in the second quarter. For the first half of fiscal 2021, the company reported sales of $2.58 billion, up by 47% from $1.75 billion in sales posted a year ago.
Why Scotts Miracle-Gro Sprouted On Tuesday After Issuing Lower Guidance
Scotts Miracle-Gro Announces Q2 Earnings; EPS Increases 37%